April is coming to a close, so it’s time for our Monthly Funding Roundup! Below are the deals in health tech funding that you need to know about.
Quartet Health, $40M Series B (New York, NY): A collaborative mental healthcare startup that leverages advanced data mapping to identify individuals who need behavioral health resources and matches them to providers and treatment.
Livongo, $44.5M Series C (Mountain View, CA): Making diabetes management easier with a connected meter for real-time insights and personalized coaching.
CrossChx, $15M Series C (Columbus OH): CrossChx has developed Queue, a patient registration system equipped with software that captures patient data, duplicates records, catches errors in patient medical profiles, and verifies patients’ identities.
Augmedix, $17M Venture (San Francisco CA): Augmedix is “on a mission to re-humanize the doctor-patient relationship” by leveraging Google Glass to help physicians document and recall patient data in the EHR.
Genomind, $17.95M Venture (Chalfont, PA): Genomind has developed a cheek-swab genetic test to help clinicians determine effective treatment options for patients with mental illness.
Proteus Health, $50M Series H (Redwood City, CA): Leading the way in “Digital Medicine” Proteus Health has developed Discover, a wearable patch and connected app that helps providers collect patient data and determine effective treatment pathways.
Bright Health, $80M Series A (Minnesota City, MN): Bright Health promises affordable health plans, integrated technology, and incentives for physicians to practice value-based care.
ChartSpan, $3.2M Venture (Greenville, SC): A free app that allows patients to organize and request health records from their smartphones.
Naya Health, $3.9M Seed (Redwood City California): Smart breast pump and connected app
BioBeats, $2.28M Venture (Berkeley, CA): Machine learning platform that pulls biometric data from wearable and smart devices and provides real-time insight about users’ wellbeing.
ApolloMed, $5M Venture (Glendale CA): “ApolloMed is a leading physician-driven, patient centric, integrated healthcare company providing inpatient and outpatient care for physicians and large patient populations.”
EmboMedics, $4.3M Series A (Maple Grove, MN): “A new bioresorbable embolic bead technology blocks blood vessels supplying tumors without causing long term blockage of the blood vessels of healthy tissue. These bioresorbable embolic beads offer the potential for controlled and predictable drug release and bead absorbtion.”
Tear Science, $19.23 Series D (Morrisville NC): “Facilitating early detection and treatment of prevalent, chronic and progressive Meibomian Gland Disease (MGD).”
Voxell0, $1.2M Series A (Coralville IA): “Voxello provides solutions for hospitalized patients who cannot communicate by traditional means.”
MedPilot, $750K Angel (New York, NY): “Improve patient billing, collections, and satisfaction with effective, flexible tools.”
Profusa, $1.75M Grant (San Francisco CA): “Leading the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease.”
Eligible,$25.2M Angel, (Brooklyn, NY): “API for Coverage, Claims, Payment Status and Reports.”
REACH Health, $2.25M Venture (Alpharetta GA): “REACH Health is a technology company specializing in developing and providing interactive physician-to-patient telemedicine and telestroke solutions.”
HealthVerity, $7.19 Series A (Philadelphia, PA): “Technologies and software tools to discover and integrate the optimal patient data set.”
Clear Guide Medical, $3M Series A (Baltimore, MD): “A medical device company focused on advanced software and minimal hardware. We create cost-effective devices to enable more accurate and efficient medical procedures.”
Capture Vascular Systems, $2.59M Venture (Telluride,CO): “Capture Vascular is an early stage medical device company that has a platform catheter technology for thrombectomy.”
PowerVision, $10M Series D (Belmost, CA): “The FluidVisionTM accommodating intraocular lens (IOL) is designed to restore the vision of youth to the middle aged or elderly individuals affected by presbyopia and/or cataracts.”
EverylyWell, $2.5M Seed (Austin TX): “EverlyWell believes that diagnostic tests shouldn’t be hard to get. We provide convenient, at-home health tests with results you can actually understand.”
Forward Health Group, $4M Venture (Madison, WI): “Forward Health Group helps providers improve outcomes via population health management thru its PopulationManager data visualization and analytics.”
Innara Health, $1.25M Venture (Olathe, KS): “Innara Health is a neonatal medical device company developing new feeding technologies and neurodevelopmental care for premature, newborn and full infants and children.”
SafeOp Surgical $1.75M Venture (Hunt Valley, MD): “SafeOp produces easy to use neuromonitoring devices to help caregivers prevent nerve damage in any type of surgical procedure.”
Direct Flow Medical, $30.98M Series C (Santa Rosa, CA): “The Direct Flow Medical system is designed to treat aortic stenosis with minimal risk of aortic regurgitation, a significant clinical complication with current transcatheter aortic heart valve replacement (TAVR) systems.”
GibLib, $1M Venture: A platform for watching surgical videos, sharing materials with the community, and discussing procedures.
CapsoVision, $4.6M Venture (Saratoga, CA):Company developing gastrointestinal medical devices
Ocuhub, 1.75M Venture (Marietta Georgia): “OcuHub is a health information platform and services company helping Payers, Health Systems and Doctors integrate eyecare services into mainstream healthcare delivery to improve outcomes, quality and reduce costs.”
Abby Ballou is the managing editor of MedTech Boston. She has a B.A. and M.Phil in English literature from NYU and the CUNY Graduate Center, respectively. When she isn't writing and editing for MedTech Boston, Abby enjoys reading, rock climbing, watching classic movies and listening to opera.
Send this to a friend